Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel AML Characterization Test
Comprehensive Introduction to AML Characterization Testing
Immunophenotyping by Flow Cytometry represents a cornerstone in modern hematological diagnostics, providing unprecedented precision in characterizing acute myeloid leukemia (AML) subtypes. This advanced diagnostic panel utilizes sophisticated flow cytometry technology to analyze the unique surface and intracellular markers expressed by leukemic cells, enabling hematologists and oncologists to make accurate diagnoses and develop targeted treatment strategies. The importance of precise AML characterization cannot be overstated, as different AML subtypes respond differently to various therapeutic approaches, making accurate classification essential for optimal patient outcomes.
What This Advanced Test Measures and Detects
The Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel AML Characterization Test employs cutting-edge technology to measure and analyze multiple cellular markers simultaneously:
- Surface Antigen Analysis: Detects specific cell surface markers including CD13, CD33, CD117, HLA-DR, and CD34
- Lineage Determination: Identifies myeloid, monocytic, megakaryocytic, and erythroid lineage markers
- Maturation Stage Assessment: Evaluates the differentiation stage of leukemic blasts
- Aberrant Marker Expression: Detects abnormal antigen expression patterns characteristic of specific AML subtypes
- Minimal Residual Disease Monitoring: Provides baseline data for future treatment response assessment
Technical Methodology
This test utilizes multi-parameter flow cytometry with advanced laser technology and fluorescent antibody conjugates to analyze thousands of cells per second. The sophisticated instrumentation allows for simultaneous detection of multiple cellular markers, providing a comprehensive immunophenotypic profile that supports accurate WHO classification of AML subtypes.
Who Should Consider This Essential Diagnostic Test
This comprehensive AML characterization test is recommended for individuals presenting with specific clinical indications:
- Unexplained Cytopenias: Patients with persistent anemia, thrombocytopenia, or neutropenia without clear cause
- Abnormal Blood Counts: Individuals with elevated white blood cell counts, particularly with circulating blasts
- Suspected Hematological Malignancies: Patients with clinical symptoms suggestive of leukemia
- Bone Marrow Abnormalities: Individuals with abnormal bone marrow findings requiring further characterization
- Treatment Planning: Patients diagnosed with AML requiring precise subtype classification for targeted therapy
- Disease Monitoring: Individuals undergoing treatment for AML requiring baseline immunophenotypic data
Symptom Presentation
Common symptoms that may indicate the need for AML characterization include persistent fatigue, unexplained bruising or bleeding, recurrent infections, bone pain, night sweats, and unexplained weight loss. Early detection and precise characterization are crucial for initiating appropriate treatment promptly.
Significant Benefits of AML Immunophenotyping
Undergoing this comprehensive diagnostic panel offers multiple advantages for both patients and healthcare providers:
- Precise Diagnosis: Enables accurate classification of AML subtypes according to WHO standards
- Targeted Treatment Selection: Guides selection of appropriate chemotherapy regimens and targeted therapies
- Prognostic Information: Provides valuable prognostic indicators based on immunophenotypic patterns
- Rapid Results: Offers same-day reporting when samples are received by 9 am
- Comprehensive Analysis: Provides multi-parameter assessment of leukemic cell characteristics
- Treatment Monitoring Baseline: Establishes baseline data for future minimal residual disease assessment
- Cost-Effective Diagnosis: Available at a discounted price of $362 USD compared to the regular $500 USD
Understanding Your Test Results
Interpreting the results of the Immunophenotyping by Flow Cytometry AML Characterization Test requires specialized hematological expertise:
- Positive for AML: Indicates the presence of immunophenotypic markers consistent with acute myeloid leukemia
- Subtype Classification: Results will specify the AML subtype based on WHO classification criteria
- Marker Expression Patterns: Detailed report of specific antigen expression supporting the diagnosis
- Blast Percentage: Quantification of leukemic blast population in the sample
- Lineage Assignment: Clear identification of the predominant cell lineage involved
Clinical Correlation
It’s essential to interpret these results in conjunction with clinical presentation, morphological findings, and cytogenetic/molecular studies. Your hematologist or oncologist will integrate all available data to develop a comprehensive treatment plan tailored to your specific AML subtype.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $362 |
| Regular Price | $500 |
Sample Requirements and Processing
Turnaround Time: Sample Daily by 9 am; Report Same-day
Sample Type: 3 mL (2 mL min.) whole blood each in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium heparin) tube AND Aspirate Smear
Shipping Instructions: Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE
Pre-test Requirements: Clinical history is mandatory
Nationwide Accessibility and Booking Information
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art flow cytometry laboratories maintain the highest standards of quality and accuracy.
Take Action for Your Health
Don’t delay in obtaining the precise diagnostic information needed for optimal leukemia management. Our expert team of hematologists and flow cytometry specialists are ready to provide you with comprehensive AML characterization services. Contact us today to schedule your test and take the first step toward accurate diagnosis and targeted treatment.
Book Your Test Today: Call or WhatsApp +1(267) 388-9828 to schedule your Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel AML Characterization Test. Our knowledgeable staff will guide you through the process and answer any questions you may have about this essential diagnostic procedure.
